What does the "godfather of technical analysis" make of recent calls for a gigantic correction? Not much.» Read More
The Duchess of Cambridge’s brother, James Middleton, hopes his business idea will get him the royal treatment: turning Instagram snaps into marshmallows.
HealthCare.gov won't disclose some key details of Obamacare, including how many people have paid, insurer market share and proposed 2015 prices.
The algorithm Google designed to rid the Internet of spammy links is proving difficult, if not impossible, to control.
The notion that a lot of the current upset could be traced back to a Death Cross in the 10-year Treasury yield seems as plausible as any.
While many financial advisors help clients set up 529 savings plans, some work with families through the entire college app process.
Most everyone reaches a point where managing one's money is too hard. Here's how to know when Mom or Dad needs help, and how best to give it.
Using the CNBC RQ 50 measure for R&D productivity, we've identified an elite group of companies that merit election to an R&D hall of fame.
Investors seeking steady gains on innovation should look past tech buzz. When R&D productivity is measured, 'boring' stocks often lead.
The wave of innovation will eliminate even more blue-collar jobs and it could also threaten significant numbers of white-collar workers.
Blackstone Advisory Partners Vice Chairman Byron Wien tells CNBC that the fundamentals are sound but investors have become too complacent.
U.K. policymakers are set to woo the burgeoning bitcoin industry, with a new study looking at the opportunities involved with the technology.
Stocks will significantly outperform bonds in the years ahead as investors get used to rising interest rates, according to Goldman Sachs.
If Amazon keeps rolling for another 25 years, companies in even more sectors will need to protect their turf. Are any retailers truly safe?
Yahoo CEO Marissa Mayer's actual accomplishments during her two-year tenure leave much to be desired, Eric Jackson said.
Expect a shakeup in the restaurant rankings if Janney's predictions for America's top 10 restaurant chains in 2020 are correct.
The muted recovery, now more than 5 years old, has lacked one vital thing: more corporate spending. That's about to change, a survey shows.
Terminally ill patients are increasingly seeking access experimental drugs outside clinical trials, but drug companies often decline these requests. A look at why.
As Alibaba dips into the US and onto Amazon's home turf, a little-known start-up called AppFlood may be among its best allies.
Goldman Sachs is cutting off some hedge fund clients and even pulling cash from its own hedge funds as it looks to cope with tough new banking rules.
There's skepticism among some observers over whether the Indian stock market can continue to rally after a nearly 30 percent gain so far in 2014.